Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 245 recruiting now early-phase tilt #5 of 28,707 conditions

Depression: early-phase trial registry

245 of 687 indexed Depression trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5 of 28,707 conditions by registered trial count.

687 US clinical trials · 245 currently recruiting · #5 of 28,707 conditions by registered trial count

Depression: 687 US clinical trials tracked, 245 recruiting.

Depression is the subject of 687 registered US clinical trials on ClinicalTrials.gov, 245 of them currently open to new participants. 70 are in Phase 3-4 (later-stage) and 111 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 29 of these trials.

Enrollment posture brief

Registry condition depression

OPEN 245 | RECR 36% | LATE 70 | EARLY 111 | RANK #5 | SPON 29

Nearest open-share peer: Pancreatic Cancer (36% recruiting · 283 trials)

Cancer44.9%Prostate Cancer36.7%Depression (this)36%Hypertension32.2%HIV Infections9.1%
Open-enrollment share among volume-matched conditions near Depression

Depression lists 245 open slots (36% of 687 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Depression on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression recruits in line with its size-band peers.

    245 of 687 indexed trials (35.7%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depression trials is spread across many organizations.

    Massachusetts General Hospital accounts for 29 of 687 trials (4.2%). 231 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depression enrolment sits around 100 participants.

    Median target enrolment is 100 among the 680 trials that report a genuine target (sentinel values excluded). 331 of those (48.7%) plan for fewer than 100 participants.

  4. Depression research is mostly interventional.

    618 interventional and 69 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 141Phase 270Phase 329Phase 441

Open and recent trials

687 total, page 9 of 14

COMPLETED 283 participants

Antidepressant Use During Pregnancy

University of Pittsburgh

NCT00279370

COMPLETED NA 277 participants

Toddler Overweight Prevention Study Among Low-Income Families

University of Maryland, Baltimore

NCT02615158

COMPLETED Phase 2 275 participants

Low-intensity Stepped Care for Internalizing Distress

Indiana University

NCT05441111

COMPLETED NA 271 participants

An Integrated Model of Primary Care in Mental Health

US Department of Veterans Affairs

NCT00013260

COMPLETED Phase 2 265 participants

Sunshine 2 Study for Women With Diabetes

Loyola University

NCT01904032

COMPLETED Phase 4 263 participants

ADAPT: Addressing Depression and Pain Together

University of Pittsburgh

NCT01124188

COMPLETED 241 participants

Reward-Related Processes and Brain Function

National Institute of Mental Health (NIMH)

NCT00029588

COMPLETED 240 participants

Mothers With a History of Depression and Their 10-14 Year Old Daughters

Stanford University

NCT01129752

COMPLETED NA 240 participants

Telephone Calls for Health for Homebound Older Adults

University of Texas at Austin

NCT04595708

COMPLETED Phase 4 238 participants

Effectiveness of Supplemental Calcium in Preventing Postpartum Depression

Oregon Health and Science University

NCT00228033

COMPLETED NA 232 participants

Family-centered Mental Health Promotion Intervention

University of Massachusetts, Amherst

NCT04453709

COMPLETED NA 231 participants

Personalized Antidepressant Adherence Strategies For Depressed Elders

Weill Medical College of Cornell University

NCT01301859

COMPLETED NA 230 participants

Comparison of Three Electroconvulsive Therapy (ECT) Techniques for the Treatment of Major Depression

University of Medicine and Dentistry of New Jersey

NCT00069407

COMPLETED NA 230 participants

Preventing Maternal Depression In Head Start

Boston Medical Center

NCT01298804

COMPLETED Phase 2 226 participants

Reducing Symptoms of Depression in Low-Income Mothers

University of North Carolina, Chapel Hill

NCT00074789

COMPLETED NA 226 participants

Intervention Trial to Reduce Mental Health Disparities in Latina Immigrant Women

University of Washington

NCT03545282

COMPLETED Phase 3 221 participants

Therapy for Depressed Elders With Thought Problems

University of Washington

NCT00052091

COMPLETED NA 220 participants

Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Subjects Exhibiting Neuropsychiatric Disorders

AltheaDx

NCT02411123

COMPLETED Phase 1 217 participants

Reducing Health Risk Behavior and Improving Health in Adolescents With Depression

University of California, Los Angeles

NCT00461539

COMPLETED NA 211 participants

Telemedicine for Improved Delivery of Psychosocial Treatments for Post Traumatic Stress Disorder

Veterans Medical Research Foundation

NCT01158001

COMPLETED NA 210 participants

Chatbot for Depression, Anxiety, and Eating Disorders

Dartmouth-Hitchcock Medical Center

NCT06013137

COMPLETED NA 210 participants

Spanish Intervention for Caregivers of Veterans With Stroke

VA Office of Research and Development

NCT03142841

COMPLETED NA 203 participants

The Clinic Treatment Project

Judge Baker Children's Center

NCT01178554

COMPLETED NA 202 participants

Shared Decision-Making for Elderly Depressed Primary Care Patients

Weill Medical College of Cornell University

NCT01031134

COMPLETED NA 201 participants

Preventing Post-Stroke Depression

Robert G. Robinson

NCT00071643

COMPLETED NA 199 participants

Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression

Maurizio Fava, MD

NCT00101452

COMPLETED NA 187 participants

Quality IQ Patient Simulation Physician Practice Measurement and Engagement

Qure Healthcare

NCT03800901

COMPLETED NA 185 participants

Brief Cognitive Behavioral Therapy (CBT) for Pediatric Anxiety and Depression in Primary Care

San Diego State University

NCT01147614

COMPLETED NA 184 participants

Loving-Kindness Meditation for PTSD

VA Office of Research and Development

NCT01962714

COMPLETED NA 182 participants

Integrating Depression Services Into DM Management

University of Pennsylvania

NCT01098253

COMPLETED NA 180 participants

Sequenced vs. Integrated Delivery of Treatment for Adolescent Depression and SUD

Oregon Research Institute

NCT00680966

COMPLETED Phase 4 180 participants

Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression

New York State Psychiatric Institute

NCT00487500

COMPLETED NA 179 participants

A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression

Mayo Clinic

NCT02286440

COMPLETED NA 178 participants

Brief Peer Supported webSTAIR Compared to Enhanced Wait List

Palo Alto Veterans Institute for Research

NCT04286165

COMPLETED Phase 2 172 participants

Perimenopausal Estrogen Replacement Therapy Study

University of North Carolina, Chapel Hill

NCT01308814

COMPLETED 163 participants

Stress and Coping in Caregivers of Younger Patients With Cancer

Wake Forest University Health Sciences

NCT02725385

COMPLETED NA 160 participants

Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans

Veterans Medical Research Foundation

NCT01253044

COMPLETED Phase 4 160 participants

Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

University of Nebraska

NCT00536172

COMPLETED NA 159 participants

Integrative Medicine Group Visits: A Patient-Centered Approach to Reducing Chronic Pain and Depression

Boston Medical Center

NCT02262377

COMPLETED NA 158 participants

Depression and Self-care in Heart Failure

Washington University School of Medicine

NCT01028625

COMPLETED Phase 3 156 participants

Treatments for Depression: Drug Versus Psychotherapy

University of Pennsylvania

NCT00043550

COMPLETED NA 156 participants

Text Based Digital Interventions Prompting Enjoyable and Healthy Behaviors

Florida State University

NCT06492824

COMPLETED Phase 1 154 participants

Intravenous Ketamine Plus Neurocognitive Training for Depression

Rebecca Price

NCT03237286

COMPLETED NA 153 participants

Collaborative Care for Women Veterans

VA Office of Research and Development

NCT02950961

COMPLETED Phase 2 150 participants

Study of a Self-Help Depression Skills Program for College-Aged Youth

Kaiser Permanente

NCT00145054

COMPLETED Phase 3 150 participants

Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth

Wayne State University

NCT01594606

COMPLETED NA 150 participants

Participatory Messaging in the UCLA Psychiatry Partial Hospitalization and Intensive Outpatient Programs

University of California, Los Angeles

NCT02708940

COMPLETED Phase 2 150 participants

Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy

Massachusetts General Hospital

NCT00338767

COMPLETED NA 150 participants

Cognitive Behavioral Therapy for Depression: Helping Clients Learn New Skills

Ohio State University

NCT04673513

COMPLETED Phase 1 150 participants

Comparison of Depression Interventions After Acute Coronary Syndrome

Columbia University

NCT01032018

← Previous Page 9 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 41
Phase 2 70
Phase 3 29
Phase 4 41

Named interventions

Most-linked intervention names on Depression records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
29 trials
Ketamine Drug
11 trials
Escitalopram Drug
11 trials
Psilocybin Drug
8 trials
Placebo Other
8 trials
Sertraline Drug
6 trials
Cognitive Behavioral Therapy Behavioral
5 trials
Duloxetine Drug
5 trials

US sites by state

Facility locations filed on Depression trials. A trial with sites in several states counts in each.

California 116 trials
New York 88 trials
Massachusetts 70 trials
Texas 58 trials
Pennsylvania 54 trials
Florida 49 trials
Maryland 42 trials
North Carolina 38 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Depression page

687 registered trials, 245 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Depression condition card totals 687 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.